Orbimed Advisors

OrbiMed is a global investment firm focused on the healthcare industry. They aim to invest in world-class healthcare companies to drive innovation, address unmet medical needs, and improve patient outcomes. They focus on long-term growth trends led by global demographics and scientific innovation in treating disease. OrbiMed believes the healthcare industry's powerful growth profile, coupled with its magnitude and complexity, creates numerous investment opportunities. Their investment strategy is broad and flexible, covering the global healthcare industry from seed-stage venture capital to large publicly-traded companies. They invest through public equity, private equity, and private credit/royalty strategies. In private equity, OrbiMed often acts as a lead investor, actively helping portfolio companies to become market leaders, with a global investment scope including North America, Asia, and Europe. They also offer non-dilutive structured debt capital and royalty monetization solutions to commercial-stage healthcare companies and intellectual property owners. OrbiMed invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services. They seek companies focused on responsible, sustainable growth to build long-term shareholder value. They have been investing globally for over 25 years and currently manage approximately $20 billion across public and private company investments worldwide.

Biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, healthcare information technology, healthcare services, gene editing, AI-guided drug discovery, liquid biopsy, oncology, immunology, inflammation, fibrotic diseases, messenger RNA targeting, antibody therapies, ADC oncology therapies

Core thematic spaces, technologies, and target market segments of interest.